Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into the Rollout

Version 1 : Received: 6 March 2024 / Approved: 6 March 2024 / Online: 6 March 2024 (12:07:28 CET)

A peer-reviewed article of this Preprint also exists.

Ndoula, S.T.; Mboussou, F.; Njoh, A.A.; Nembot, R.; Baonga, S.F.; Njinkeu, A.; Biey, J.; Kaba, M., II; Amani, A.; Farham, B.; Kouontchou Mimbe, J.-C.; Kouakam, C.A.; Volkmann, K.; Dadjo, C.H.; Habimana, P.; Impouma, B. Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout. Vaccines 2024, 12, 346. Ndoula, S.T.; Mboussou, F.; Njoh, A.A.; Nembot, R.; Baonga, S.F.; Njinkeu, A.; Biey, J.; Kaba, M., II; Amani, A.; Farham, B.; Kouontchou Mimbe, J.-C.; Kouakam, C.A.; Volkmann, K.; Dadjo, C.H.; Habimana, P.; Impouma, B. Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout. Vaccines 2024, 12, 346.

Abstract

Cameroon introduced the malaria vaccine in its routine immunization programme on 22 January 2024, in the 42 districts out of 200, among the most at risk of malaria. A cross-sectional analysis of data on vaccine key events in the introduction roadmap and vaccine uptake during the first 30 days was conducted. In addition to available gray literature related to the introduction of the malaria vaccine, data on malaria vaccine uptake by vaccination session, collected through a digital platform, were analyzed. A total of 1,893 reports were received from 22 January 2024 to 21 February 2024 from 766 health facilities (85% of overall completeness). Two regions out of 10 recorded less than 80% of completeness. As of 21 February 2024, 13,811 children have received the first dose of the malaria vaccine, including 7,124 girls (51.6%) and 6,687 boys (48.4%). Thirty six percent of children were vaccinated through outreach sessions versus 61.5% through sessions in fixed posts. The overall monthly immunization coverage with the first dose was 37%. Early results have shown positive attitudes towards and acceptance of malaria vaccines. Suboptimal completeness of data reporting and low coverage highlight persistent gaps and challenges in vaccine rollout.

Keywords

Malaria vaccine; Cameroon; new vaccine introduction; Africa.

Subject

Public Health and Healthcare, Public Health and Health Services

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.